Literature DB >> 12118167

Genetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis.

Matthew A Brown1, Alison M Crane, B Paul Wordsworth.   

Abstract

While twin studies have previously demonstrated high heritability of susceptibility to ankylosing spondylitis (AS), it is only recently that the involvement of genetic factors in determining the severity of the disease has been demonstrated. The genes involved in determining the rate of ankylosis in AS are likely to be different from those involved in the underlying immunologic events, and represent important potential targets for treatment of AS. This article will describe the progress that has been made in the genetic epidemiology of AS, and in identifying the genes involved.

Entities:  

Mesh:

Year:  2002        PMID: 12118167     DOI: 10.1097/00002281-200207000-00004

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  6 in total

1.  Lack of association between ankylosing spondylitis and a functional polymorphism of PTPN22 proposed as a general susceptibility marker for autoimmunity.

Authors:  G Orozco; C García-Porrúa; M A López-Nevot; E Raya; M A González-Gay; J Martín
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

2.  Two distinct patterns of ankylosing spondylitis in Moroccan patients.

Authors:  Laila El Mansouri; Rachid Bahiri; Fatima Ezzahra Abourazzak; Radouan Abouqal; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2009-03-04       Impact factor: 2.631

3.  An evaluation of anti-TNF-alpha-therapy in patients with ankylosing spondylitis: imbalanced activation of NF kappa B subunits in lymphocytes and modulation of serum cortisol concentration.

Authors:  Martin Eggert; Ulrike Seeck; Marco Semmler; Ulrich Maass; Sabine Dietmann; Martin Schulz; Helmut Dotzlaw; Gunther Neeck
Journal:  Rheumatol Int       Date:  2007-01-23       Impact factor: 3.580

4.  Immune cell infiltration-related clinical diagnostic model for Ankylosing Spondylitis.

Authors:  Chenxing Zhou; Tuo Liang; Jie Jiang; Zide Zhang; Jiarui Chen; Tianyou Chen; Liyi Chen; Xuhua Sun; ShengSheng Huang; Jichong Zhu; Shaofeng Wu; Xinli Zhan; Chong Liu
Journal:  Front Genet       Date:  2022-09-05       Impact factor: 4.772

5.  Phenotype difference between familial and sporadic ankylosing spondylitis in Korean patients.

Authors:  Hye Won Kim; Hye Rim Choe; Su Bin Lee; Won Ik Chang; Hyun Jun Chae; Jin Young Moon; Jisue Kang; Sungim Lee; Yeong Wook Song; Eun Young Lee
Journal:  J Korean Med Sci       Date:  2014-05-30       Impact factor: 2.153

6.  Active ankylosing spondylitis increases blood loss during total hip arthroplasty for a stiff hip joint.

Authors:  Yong Hu; Wei-Zhou Jiang; Cheng-Long Pan; Tao Wang
Journal:  BMC Musculoskelet Disord       Date:  2020-04-15       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.